@misc{indiciae89c31402225f,
  title = {Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.},
  author = {M Cruellas and A Rodriguez-Hernandez and L Carit\&\#xe0; and E Segu\&\#xed; and M Cejuela and L Lema and E Garc\&\#xed;a-Torralba and A Roqu\&\#xe9;-Lloveras and A Fern\&\#xe1;ndez-Ortega and M Mel\&\#xe9; and M Tapia and S Servitja and S Gonz\&\#xe1;lez-Santiago and N Blaya-Boluda and M Bellet and O Mart\&\#xed;nez-S\&\#xe1;ez and I Pimentel and I Garc\&\#xed;a-Fructuoso and T Pascual and L Joval-Ramentol and G Vi\&\#xf1;as and M Rey Aceituno and A Casas and E Castillo and F Bras\&\#xf3;-Maristany and A Vivancos and V Serra and G Villacampa and M Oliveira and A Prat and C Saura and B Adamo and J Balma\&\#xf1;a},
  year = {2026},
  doi = {10.1016/j.esmoop.2026.108335},
  url = {https://pubmed.ncbi.nlm.nih.gov/42485699/},
  note = {Source identifier: 42485699}
}